{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:35:33Z","timestamp":1792668933420,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL111130"],"award-info":[{"award-number":["R01 HL111130"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.trsl.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T19:21:10Z","timestamp":1554405670000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Fibrosis and secondary lymphedema: chicken or egg?"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1315-7982","authenticated-orcid":false,"given":"Raghu P.","family":"Kataru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Wiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Eun","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeung Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Yeon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Mehrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2019.04.001_bib0001","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2776::AID-CNCR25>3.0.CO;2-V","article-title":"Incidence of breast carcinoma-related lymphedema","volume":"83","author":"Petrek","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2019.04.001_bib0002","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","article-title":"Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis","volume":"92","author":"Petrek","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2019.04.001_bib0003","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","article-title":"The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors","volume":"16","author":"Tsai","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0004","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1002\/cncr.25458","article-title":"Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema","volume":"116","author":"Cormier","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2019.04.001_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1196\/annals.1413.014","article-title":"Estimating the population burden of lymphedema","volume":"1131","author":"Rockson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trsl.2019.04.001_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2019.04.001_bib0007","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumat"},{"key":"10.1016\/j.trsl.2019.04.001_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.trsl.2019.04.001_bib0009","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1038\/ncomms12408","article-title":"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040","volume":"7","author":"Arthur","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.04.001_bib0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.trsl.2019.04.001_bib0011","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1746-1561.1992.tb08195.x","article-title":"Multiple correlates of cigarette use among high school students","volume":"62","author":"McDermott","year":"1992","journal-title":"J Sch Health"},{"key":"10.1016\/j.trsl.2019.04.001_bib0012","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-060116-022900","article-title":"Lymphedema: pathogenesis and novel therapies","volume":"69","author":"Dayan","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.trsl.2019.04.001_bib0013","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2017.07.052","article-title":"Health-related quality of life in melanoma patients: impact of melanoma-related limb lymphoedema","volume":"85","author":"Gjorup","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trsl.2019.04.001_bib0014","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","article-title":"Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study","volume":"27","author":"Shih","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI15830","article-title":"VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema","volume":"111","author":"Yoon","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.04.001_bib0016","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/CIRCULATIONAHA.110.965384","article-title":"Growth factor therapy and autologous lymph node transfer in lymphedema","volume":"123","author":"Lahteenvuo","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2019.04.001_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/303019","article-title":"Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase","volume":"67","author":"Irrthum","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2019.04.001_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmg.2004.024802","article-title":"Milroy disease and the VEGFR-3 mutation phenotype","volume":"42","author":"Brice","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2019.04.001_bib0019","first-page":"185","article-title":"Serum level of VEGF-D in patients with primary lymphedema","volume":"37","author":"Fink","year":"2004","journal-title":"Lymphology"},{"key":"10.1016\/j.trsl.2019.04.001_bib0020","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.14814\/phy2.12403","article-title":"Higher vascular endothelial growth factor-C concentration in plasma is associated with increased forearm capillary filtration capacity in breast cancer-related lymphedema","volume":"3","author":"Jensen","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1016\/j.trsl.2019.04.001_bib0021","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jid.2017.04.033","article-title":"An important role of VEGF-C in promoting lymphedema development","volume":"137","author":"Gousopoulos","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0022","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2010.12.016","article-title":"T lymphocytes negatively regulate lymph node lymphatic vessel formation","volume":"34","author":"Kataru","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.04.001_bib0023","first-page":"101","article-title":"Lymphedema after breast and gynecological cancer - a frequent, chronic, disabling condition in cancer survivors","volume":"23","author":"Planinsek Rucigaj","year":"2015","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.trsl.2019.04.001_bib0024","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","article-title":"Lymphedema after breast cancer treatment","volume":"379","author":"Rockson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.04.001_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1158\/0008-5472.CAN-07-2454","article-title":"Acquired lymphedema: an urgent need for adequate animal models","volume":"68","author":"Hadamitzky","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.04.001_bib0026","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI71608","article-title":"New developments in clinical aspects of lymphatic disease","volume":"124","author":"Mortimer","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.04.001_bib0027","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mvr.2006.05.009","article-title":"Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9","volume":"72","author":"Rutkowski","year":"2006","journal-title":"Microvasc Res"},{"key":"10.1016\/j.trsl.2019.04.001_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/jbio.201700132","article-title":"Imaging lymphatics in human normal and lymphedema limbs-Usefulness of various modalities for evaluation of lymph and edema fluid flow pathways and dynamics","volume":"11","author":"Zaleska","year":"2018","journal-title":"J Biophotonics"},{"key":"10.1016\/j.trsl.2019.04.001_bib0029","doi-asserted-by":"crossref","first-page":"e41126","DOI":"10.1371\/journal.pone.0041126","article-title":"Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic vessels after lymphadenectomy","volume":"7","author":"Mihara","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.04.001_bib0030","doi-asserted-by":"crossref","first-page":"e84095","DOI":"10.1172\/jci.insight.84095","article-title":"Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema","volume":"1","author":"Gardenier","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2019.04.001_bib0031","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archsurg.2010.231","article-title":"Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study","volume":"145","author":"Kwan","year":"2010","journal-title":"Arch Surg"},{"key":"10.1016\/j.trsl.2019.04.001_bib0032","doi-asserted-by":"crossref","first-page":"C589","DOI":"10.1152\/ajpcell.00535.2009","article-title":"Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis","volume":"299","author":"Avraham","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0033","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1038\/ncomms7196","article-title":"TH2 cells and their cytokines regulate formation and function of lymphatic vessels","volume":"6","author":"Shin","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.04.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126908","article-title":"Th2 cytokines inhibit lymphangiogenesis","volume":"10","author":"Savetsky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.04.001_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0036","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.153.2.753","article-title":"Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis","volume":"153","author":"Cheever","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0037","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/jhep.2001.26376","article-title":"Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis","volume":"34","author":"Chiaramonte","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2019.04.001_bib0038","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.04.001_bib0039","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1371\/journal.pmed.0030254","article-title":"Inflammatory manifestations of experimental lymphatic insufficiency","volume":"3","author":"Tabibiazar","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.trsl.2019.04.001_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms18010171","article-title":"Inflammatory manifestations of lymphedema","volume":"18","author":"Ly","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2019.04.001_bib0041","doi-asserted-by":"crossref","first-page":"e8380","DOI":"10.1371\/journal.pone.0008380","article-title":"Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice","volume":"4","author":"Nakamura","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.04.001_bib0042","doi-asserted-by":"crossref","first-page":"e123775","DOI":"10.1172\/jci.insight.123775","article-title":"Pilot studies demonstrate the potential benefits of anti-inflammatory therapy in human lymphedema","volume":"3","author":"Rockson","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2019.04.001_bib0043","doi-asserted-by":"crossref","first-page":"eaal3920","DOI":"10.1126\/scitranslmed.aal3920","article-title":"Leukotriene B4 antagonism ameliorates experimental lymphedema","volume":"9","author":"Tian","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2019.04.001_bib0044","doi-asserted-by":"crossref","first-page":"e49940","DOI":"10.1371\/journal.pone.0049940","article-title":"CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis","volume":"7","author":"Zampell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.04.001_bib0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1096\/fj.12-222695","article-title":"Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema","volume":"27","author":"Avraham","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2019.04.001_bib0046","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.ajpath.2016.04.006","article-title":"Prominent lymphatic vessel hyperplasia with progressive dysfunction and distinct immune cell infiltration in lymphedema","volume":"186","author":"Gousopoulos","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0047","doi-asserted-by":"crossref","first-page":"e89081","DOI":"10.1172\/jci.insight.89081","article-title":"Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function","volume":"1","author":"Gousopoulos","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2019.04.001_bib0048","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41467-018-04418-y","article-title":"CD4(+) T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema","volume":"9","author":"Garcia Nores","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.04.001_bib0049","doi-asserted-by":"crossref","first-page":"H1065","DOI":"10.1152\/ajpheart.00598.2014","article-title":"Regulation of inflammation and fibrosis by macrophages in lymphedema","volume":"308","author":"Ghanta","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0050","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1038\/ncomms14345","article-title":"Topical tacrolimus for the treatment of secondary lymphedema","volume":"8","author":"Gardenier","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.04.001_bib0051","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jid.2017.09.011","article-title":"Regulatory T cells mediate local immunosuppression in lymphedema","volume":"138","author":"Garcia Nores","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2019.04.001_bib0052","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trsl.2018.12.003","article-title":"T helper 2 differentiation is necessary for development of lymphedema","volume":"206","author":"Ly","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2019.04.001_bib0053","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.gastro.2013.10.027","article-title":"Increased effectiveness of early therapy with anti-tumor necrosis factor-alpha vs an immunomodulator in children with Crohn's disease","volume":"146","author":"Walters","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.04.001_bib0054","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2019.04.001_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.10.006","article-title":"The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy","volume":"74","author":"Roeleveld","year":"2015","journal-title":"Cytokine"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441930074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441930074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:38:42Z","timestamp":1761827922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152441930074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":55,"alternative-id":["S193152441930074X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2019.04.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrosis and secondary lymphedema: chicken or egg?","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}